{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:25:08Z","timestamp":1786998308813,"version":"build-2736575974"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","gynecologiconcology-online.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.ygyno.2016.03.001","type":"journal-article","created":{"date-parts":[[2016,3,14]],"date-time":"2016-03-14T18:56:06Z","timestamp":1457981766000},"page":"323-328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Prevalence and factors associated with cognitive deficit in women with gynecologic malignancies"],"prefix":"10.1016","volume":"141","author":[{"given":"Anne","family":"Van Arsdale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Rosenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis Yi-Shin","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben","family":"Barrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary L.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole S.","family":"Nevadunsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2016.03.001_bb0005","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11764-009-0098-x","article-title":"Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response","volume":"3","author":"Boykoff","year":"2009","journal-title":"J. Cancer Surviv."},{"key":"10.1016\/j.ygyno.2016.03.001_bb0010","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1080\/13803390490510905","article-title":"Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen","volume":"26","author":"Castellon","year":"2004","journal-title":"J. Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.ygyno.2016.03.001_bb0015","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/pon.1903","article-title":"Cognitive dysfunction and cancer: which consequences in terms of disease management?","volume":"20","author":"Joly","year":"2011","journal-title":"Psycho-Oncology"},{"key":"10.1016\/j.ygyno.2016.03.001_bb0020","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1002\/hbm.21102","article-title":"Cerebral hyporesponsiveness and cognitive impairment 10years after chemotherapy for breast cancer","volume":"32","author":"de Ruiter","year":"2011","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.ygyno.2016.03.001_bb0025","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3816\/CBC.2006.n.015","article-title":"Effects of high-dose and conventional-dose adjuvant chemotherapy on long-term cognitive sequelae in patients with breast cancer: an electrophysiologic study","volume":"7","author":"Kreukels","year":"2006","journal-title":"Clin. Breast Cancer"},{"key":"10.1016\/j.ygyno.2016.03.001_bb0030","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cortex.2014.01.010","article-title":"Neural correlates of chemotherapy-related cognitive impairment","volume":"54","author":"Kaiser","year":"2014","journal-title":"Cortex"},{"key":"10.1016\/j.ygyno.2016.03.001_bb0035","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10549-007-9686-5","article-title":"Cognitive function in breast cancer patients prior to adjuvant treatment","volume":"110","author":"Ahles","year":"2008","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ygyno.2016.03.001_bb0040","doi-asserted-by":"crossref","first-page":"3348","DOI":"10.1002\/cncr.25098","article-title":"Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer","volume":"116","author":"Wefel","year":"2010","journal-title":"Cancer"},{"issue":"Suppl","key":"10.1016\/j.ygyno.2016.03.001_bb0045","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.bbi.2012.05.007","article-title":"Frontal gray matter reduction after breast cancer chemotherapy and association with executive symptoms: a replication and extension study","volume":"30","author":"McDonald","year":"2013","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ygyno.2016.03.001_bb0050","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3322\/caac.21258","article-title":"Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults","volume":"65","author":"Wefel","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ygyno.2016.03.001_bb0055","article-title":"The effect of cancer treatment on cognitive function","volume":"13","author":"Asher","year":"2015","journal-title":"Clin. Adv. Hematol. Oncol."},{"key":"10.1016\/j.ygyno.2016.03.001_bb0060","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/annonc\/mdm500","article-title":"Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop","volume":"19","author":"Vardy","year":"2008","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ygyno.2016.03.001_bb0075","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2325\/jbcs.12.279","article-title":"Mild cognitive impairment after adjuvant chemotherapy in breast cancer patients\u2014evaluation of appropriate research design and methodology to measure symptoms","volume":"12","author":"Matsuda","year":"2005","journal-title":"Breast Cancer (Tokyo, Japan)"},{"key":"10.1016\/j.ygyno.2016.03.001_bb0080","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s11682-013-9244-1","article-title":"Chemotherapy altered brain functional connectivity in women with breast cancer: a pilot study","volume":"7","author":"Dumas","year":"2013","journal-title":"Brain Imaging Behav."},{"key":"10.1016\/j.ygyno.2016.03.001_bb0085","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/pon.1472","article-title":"Cognitive deficits as long-term side-effects of adjuvant therapy in breast cancer patients: \u2018subjective\u2019 complaints and \u2018objective\u2019 neuropsychological test results","volume":"18","author":"Weis","year":"2009","journal-title":"Psycho-Oncology"},{"key":"10.1016\/j.ygyno.2016.03.001_bb0090","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ygyno.2010.06.023","article-title":"Cognitive functions in long-term survivors of ovarian cancer","volume":"119","author":"Correa","year":"2010","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.03.001_bb0095","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ygyno.2011.11.005","article-title":"Cognitive function and quality of life in ovarian cancer","volume":"124","author":"Correa","year":"2012","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.03.001_bb0100","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/070674370705200508","article-title":"The Montreal Cognitive Assessment: validity and utility in a memory clinic setting","volume":"52","author":"Smith","year":"2007","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.ygyno.2016.03.001_bb0105","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.ygyno.2016.03.001_bb0110","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ygyno.2016.03.001_bb0115","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/jnci\/90.3.210","article-title":"Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy","volume":"90","author":"van Dam","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ygyno.2016.03.001_bb0120","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0304-3959(89)90169-3","article-title":"The cognitive effects of the administration of narcotic analgesics in patients with cancer pain","volume":"39","author":"Bruera","year":"1989","journal-title":"Pain"},{"key":"10.1016\/j.ygyno.2016.03.001_bb0125","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0304-3959(00)00248-7","article-title":"Neuropsychological performance in cancer patients: the role of oral opioids, pain and performance status","volume":"86","author":"Sjogren","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.ygyno.2016.03.001_bb0130","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0304-3959(97)00030-4","article-title":"Attention and somatic awareness in chronic pain","volume":"72","author":"Eccleston","year":"1997","journal-title":"Pain"},{"key":"10.1016\/j.ygyno.2016.03.001_bb0135","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.pmn.2003.11.002","article-title":"The cognitive effects of opioids","volume":"5","author":"Ersek","year":"2004","journal-title":"Pain Manag. Nurs."},{"key":"10.1016\/j.ygyno.2016.03.001_bb0140","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0305-7372(96)90026-2","article-title":"Alertness, cognition and morphine in patients with advanced cancer","volume":"22","author":"Clemons","year":"1996","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.ygyno.2016.03.001_bb0145","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1399-6576.1992.tb03501.x","article-title":"Reaction time in cancer patients receiving peripherally acting analgesics alone or in combination with opioids","volume":"36","author":"Banning","year":"1992","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.ygyno.2016.03.001_bb0150","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0885-3924(92)90060-U","article-title":"The assessment of pain intensity in patients with cognitive failure: a preliminary report","volume":"7","author":"Bruera","year":"1992","journal-title":"J. Pain Symptom Manag."},{"key":"10.1016\/j.ygyno.2016.03.001_bb0155","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(95)92281-4","article-title":"Driving ability in cancer patients receiving long-term morphine analgesia","volume":"346","author":"Vainio","year":"1995","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ygyno.2016.03.001_bb0160","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1200\/JCO.2010.32.6884","article-title":"Prevalence and predictors of cognitive dysfunction in opioid-treated patients with cancer: a multinational study","volume":"29","author":"Kurita","year":"2011","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2016.03.001_bb0165","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pon.821","article-title":"Pre-treatment factors related to cognitive functioning in women newly diagnosed with breast cancer","volume":"14","author":"Cimprich","year":"2005","journal-title":"Psycho-Oncology"},{"key":"10.1016\/j.ygyno.2016.03.001_bb0170","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ygyno.2015.10.003","article-title":"Cognitive function during and six months following chemotherapy for front line treatment of ovarian, primary peritoneal or fallopian tube cancer: an NRG oncology\/gynecologic group study","volume":"139","author":"Hess","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2016.03.001_bb0175","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/978-1-60327-323-7_37","article-title":"Non-invasive transcranial direct current stimulation for the study and treatment of neuropathic pain","volume":"617","author":"Knotkova","year":"2010","journal-title":"Methods Mol. Biol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816300580?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825816300580?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T05:53:06Z","timestamp":1536904386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825816300580"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0090825816300580"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.03.001","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and factors associated with cognitive deficit in women with gynecologic malignancies","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2016.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}